James D. Brooks

University of North Carolina at Chapel Hill — United States

Immunology and Microbiology · Life Sciences

10h-index318citations89works3.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Phagocytosis and Immune Regulation(12), Prostate Cancer Treatment and Research(11), Cancer, Lipids, and Metabolism(11), Epigenetics and DNA Methylation(10), Histone Deacetylase Inhibitors Research(8)

Publications89 total

Supporting racial, ethnic minority, and disadvantaged undergraduate nursing students with honors projects
UNC Libraries·2025Open Access
Aggressiveness classification of clear cell renal cell carcinoma using registration‐independent radiology‐pathology correlation learning
Medical Physics·2024· 7 citedOpen Access
Supplementary Figures 1-3 from Urinary TMPRSS2:ERG and PCA3 in an Active Surveillance Cohort: Results from a Baseline Analysis in the Canary Prostate Active Surveillance Study
2023Open Access
Figure S5 from S100A10 Is a Critical Mediator of GAS6/AXL–Induced Angiogenesis in Renal Cell Carcinoma
2023Open Access
Figure S3 from S100A10 Is a Critical Mediator of GAS6/AXL–Induced Angiogenesis in Renal Cell Carcinoma
2023Open Access
Figure S1 from S100A10 Is a Critical Mediator of GAS6/AXL–Induced Angiogenesis in Renal Cell Carcinoma
2023Open Access
Supplementary Movie from <i>In Vivo</i> Imaging of Methionine Aminopeptidase II for Prostate Cancer Risk Stratification
2023Open Access
Data from S100A10 Is a Critical Mediator of GAS6/AXL–Induced Angiogenesis in Renal Cell Carcinoma
2023Open Access
Data from Urinary TMPRSS2:ERG and PCA3 in an Active Surveillance Cohort: Results from a Baseline Analysis in the Canary Prostate Active Surveillance Study
2023Open Access
Supplementary Tables from S100A10 Is a Critical Mediator of GAS6/AXL–Induced Angiogenesis in Renal Cell Carcinoma
2023Open Access
Figure S3 from S100A10 Is a Critical Mediator of GAS6/AXL–Induced Angiogenesis in Renal Cell Carcinoma
2023Open Access
Figure S4 from S100A10 Is a Critical Mediator of GAS6/AXL–Induced Angiogenesis in Renal Cell Carcinoma
2023Open Access
Figure S1 from S100A10 Is a Critical Mediator of GAS6/AXL–Induced Angiogenesis in Renal Cell Carcinoma
2023Open Access
Figure S5 from S100A10 Is a Critical Mediator of GAS6/AXL–Induced Angiogenesis in Renal Cell Carcinoma
2023Open Access
Supplementary Figures 1-3 from Urinary TMPRSS2:ERG and PCA3 in an Active Surveillance Cohort: Results from a Baseline Analysis in the Canary Prostate Active Surveillance Study
2023Open Access
Supplementary Tables from S100A10 Is a Critical Mediator of GAS6/AXL–Induced Angiogenesis in Renal Cell Carcinoma
2023Open Access
Figure S2 from S100A10 Is a Critical Mediator of GAS6/AXL–Induced Angiogenesis in Renal Cell Carcinoma
2023Open Access
Supplementary Information from <i>In Vivo</i> Imaging of Methionine Aminopeptidase II for Prostate Cancer Risk Stratification
2023Open Access
Supplementary Data from Ferroptosis Inducers Are a Novel Therapeutic Approach for Advanced Prostate Cancer
2023Open Access
Data from S100A10 Is a Critical Mediator of GAS6/AXL–Induced Angiogenesis in Renal Cell Carcinoma
2023Open Access
page 1 of 5Next →

Frequent Co-authors

David Mendonça(11), Jacques Lapointe(5), Chunde Li(5), Jonathan R. Pollack(5), Geoffrey A. Sonn(3), Mirabela Rusu(3), Andrew Liu(3), Neeraja Subrahmaniyan(3), Yiren Xiao(3), Hongjuan Zhao(3), Lei Tian(3), Rosalie Nolley(3), Anh N. Diep(3), Anne Ernst(3), Katherine C. Fuh(3), Yu Rebecca Miao(3), Rie von Eyben(3), John T. Leppert(3), Donna M. Peehl(3), Amato J. Giaccia(3)